|
End-of-day quote
Lima
2026-08-14
|
5-day change | 1st Jan Change | ||
| 63.67 USD | 0.00% |
|
-2.75% | +18.21% |
| 08-17 | AstraZeneca suffers another setback as it halts volrustomig lung cancer trial | RE |
| 08-16 | Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech | RE |
Chart: Technical Analysis
Stock exchange
Lima
BMYUS 63.67 $
0.00%
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
NYSE
| BMY | 64.63USD | +1.25% | 471M $ | |
CBOE
| BMY | 64.65USD | +1.27% | 18.91M $ | |
|
Tradegate
| BRM | 55.83EUR | +1.18% | 185K € | |
|
Xetra
| BRM | 55.62EUR | +1.05% | 126K € | |
|
Deutsche Boerse AG
| BRM | 54.40EUR | -0.60% | 29.1K € | |
|
Borsa Italiana
| 1BMY | 55.61EUR | +0.93% | 26.64K € | |
|
Boerse Muenchen
| BRM | 55.77EUR | +1.03% | 26.27K € | |
|
CBOE
| 0R1F | 55.60EUR | +1.18% | 14.07K € | |
|
Mexican S.E.
| BMY * | 1,085.29MXN | -1.34% | 91.16K $ | |
|
Börse Stuttgart
| BRM | 55.66EUR | +0.74% | 4.29K € | |
|
London S.E.
| 0R1F | 63.85USD | +0.47% | 383.1 $ | |
|
Swiss Exchange
| BMY | 52.00CHF | +0.02% | 0 CHF | |
|
Swiss Exchange
| BMY | 64.22USD | +0.27% | 0 $ | |
|
Wiener Boerse
| BMYS | 55.61EUR | +0.94% | 0 € | |
|
Lima
| BMYUS | 63.67USD | 0.00% | 0 $ | |
|
CBOE
| 55.96EUR | 0.00% | 0 € | ||
Sao Paulo
| BMYB34 | 335.92BRL | +2.20% | 275K R$ | |
Buenos Aires S.E.
| BMY | 33,500.00ARS | -1.76% | 7.34M $ | |
|
Buenos Aires S.E.
| BMYD | 21.97USD | -3.85% | 65.91 $ |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BMY Stock
- BMYUS Stock
- Charts Bristol-Myers Squibb Company
Select your edition
All financial news and data tailored to specific country editions
